Transcriptional suppression of human microsomal triglyceride transfer protein by hypolipidemic insulin sensitizers

被引:9
作者
Sheena, V [1 ]
Hertz, R [1 ]
Berman, I [1 ]
Nousbeck, J [1 ]
Bar-Tana, J [1 ]
机构
[1] Hebrew Univ Jerusalem, Dept Human Nutr & Metab, IL-91120 Jerusalem, Israel
关键词
MTP; HNF-4; alpha; PPAR alpha; PPAR gamma; thiazolidinediones; Medica;
D O I
10.1016/j.bcp.2005.09.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Microsomal triglyceride transfer protein (MTP) catalyzes the assembly and secretion of liver triglyceride-rich lipoproteins. The human MTP (hMTP) promoter activity is reported here to be suppressed by HNF-4 alpha ligand antagonists (e.g., Medica analogs) or by PPAR gamma ligand agonists (e.g., thiazolidinediones), thus accounting for their hypolipidemic activity in humans. Suppression of liver hMTP by Medica analogs or by thiazolidinediones was mediated by the TAAA sequence that serves as non-canonical TATA box of the hMTP core promoter. MTP suppression was evident in the specific context of the wild type hMTP core promoter, but not in the context of the mutated rodent-conforming hMTP core promoter governed by a canonical TATA box conjoined with its proximal (-50/-38)DR-1 element. hMTP suppression by Medica analogs or thiazolidinediones mediated by hMTP TAAA was independent of HNF-4 alpha or PPAR gamma. hMTP suppression by Medica analogs, but not by thiazolidinediones, was further complemented by inhibition of HNF-4a transcriptional activity transduced by the distal (-83/-70)DR-1 element of hMTP promoter. hMTP promoter activity was unaffected by PPAR alpha activation. Furthermore, in contrast to hMTP, the promoter activity of the rodent-conforming hMTP was robustly activated by Wy-14,643-activated PPAR alpha or by thiazolidinedione-activated PPAR gamma. Transcriptional activation by PPAR alpha or PPAR-gamma of the rodent-conforming but not the wild type hMTP gene promoter, resulted from the species-specific context of the respective proximal DR-1 elements. Hence, suppression of hMTP transcription by hypolipidemic insulin sensitizers requires the specific context of hMTP core promoter. In light of the species-specific context of MTP core promoters, the rodent MTP promoter may not substitute for the human promoter when searching for hypolipidemic MTP suppressors. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1548 / 1559
页数:12
相关论文
共 39 条
[1]   Activation of peroxisome proliferator-activated receptor α increases the expression and activity of microsomal triglyceride transfer protein in the liver [J].
Améen, C ;
Edvardsson, U ;
Ljungberg, A ;
Asp, L ;
Åkerblad, P ;
Tuneld, A ;
Olofsson, SO ;
Lindén, D ;
Oscarsson, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (02) :1224-1229
[2]  
Bar-Tana Jacob, 2004, Curr Opin Investig Drugs, V5, P941
[3]   SYNTHESIS AND HYPOLIPIDEMIC AND ANTIDIABETOGENIC ACTIVITIES OF BETA,BETA,BETA',BETA'-TETRASUBSTITUTED, LONG-CHAIN DIOIC ACIDS [J].
BARTANA, J ;
BENSHOSHAN, S ;
BLUM, J ;
MIGRON, Y ;
HERTZ, R ;
PILL, J ;
ROSEKHAN, G ;
WITTE, EC .
JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (09) :2072-2084
[4]   The effect of pioglitazone on peroxisome proliferator-activated receptor-γ target genes related to lipid storage in vivo [J].
Bogacka, I ;
Xie, H ;
Bray, GA ;
Smith, SR .
DIABETES CARE, 2004, 27 (07) :1660-1667
[5]   CD1d function is regulated by microsomal triglyceride transfer protein [J].
Brozovic, S ;
Nagaishi, T ;
Yoshida, M ;
Betz, S ;
Salas, A ;
Chen, DH ;
Kaser, A ;
Glickman, J ;
Kuo, T ;
Little, A ;
Morrison, J ;
Corazza, N ;
Kim, JY ;
Colgan, SP ;
Young, SG ;
Exley, M ;
Blumberg, RS .
NATURE MEDICINE, 2004, 10 (05) :535-539
[6]   Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans? [J].
Cattley, RC ;
DeLuca, J ;
Elcombe, C ;
Fenner-Crisp, P ;
Lake, BG ;
Marsman, DS ;
Pastoor, TA ;
Popp, JA ;
Robinson, DE ;
Schwetz, B ;
Tugwood, J ;
Wahli, W .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1998, 27 (01) :47-60
[7]   CP-346086: an MTP inhibitor that lowers plasma cholesterol and triglycerides in experimental animals and in humans [J].
Chandler, CE ;
Wilder, DE ;
Pettini, JL ;
Savoy, YE ;
Petras, SF ;
Chang, G ;
Vincent, J ;
Harwood, HJ .
JOURNAL OF LIPID RESEARCH, 2003, 44 (10) :1887-1901
[8]   Liver-specific inactivation of the abetalipoproteinemia gene completely abrogates very low density lipoprotein low density lipoprotein production in a viable conditional knockout mouse [J].
Chang, BHJ ;
Liao, W ;
Li, L ;
Nakamuta, M ;
Mack, D ;
Chan, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (10) :6051-6055
[9]   Thiazolidinediones: a new class of antidiabetic drugs [J].
Day, C .
DIABETIC MEDICINE, 1999, 16 (03) :179-192
[10]   THE EFFECT OF BETA,BETA'-TETRAMETHYLHEXADECANEDIOIC ACID (MEDICA-16) ON PLASMA VERY-LOW-DENSITY LIPOPROTEIN METABOLISM IN RATS - ROLE OF APOLIPOPROTEIN C-III [J].
FRENKEL, B ;
BISHARASHIEBAN, J ;
BARTANA, J .
BIOCHEMICAL JOURNAL, 1994, 298 :409-414